Literature DB >> 16793844

Patterns of cardiovascular risk in rheumatoid arthritis.

D H Solomon1, N J Goodson, J N Katz, M E Weinblatt, J Avorn, S Setoguchi, C Canning, S Schneeweiss.   

Abstract

BACKGROUND: Although it is known that rheumatoid arthritis is associated with an increased risk of cardiovascular disease (CVD), the pattern of this risk is not clear. This study investigated the relative risk of myocardial infarction, stroke and CVD mortality in adults with rheumatoid arthritis compared with adults without rheumatoid arthritis across age groups, sex and prior CVD event status.
METHODS: We conducted a cohort study among all residents aged >or=18 years residing in British Columbia between 1999 and 2003. Residents who had visited the doctor at least thrice for rheumatoid arthritis (International Classification of Disease = 714) were considered to have rheumatoid arthritis. A non-rheumatoid arthritis cohort was matched to the rheumatoid arthritis cohort by age, sex and start of follow-up. The primary composite end point was a hospital admission for myocardial infarction, stroke or CVD mortality.
RESULTS: 25 385 adults who had at least three diagnoses for rheumatoid arthritis during the study period were identified. During the 5-year study period, 375 patients with rheumatoid arthritis had a hospital admission for myocardial infarction, 363 had a hospitalisation for stroke, 437 died from cardiovascular causes and 1042 had one of these outcomes. The rate ratio for a CVD event in patients with rheumatoid arthritis was 1.6 (95% confidence interval (CI) 1.5 to 1.7), and the rate difference was 5.7 (95% CI 4.9 to 6.4) per 1000 person-years. The rate ratio decreased with age, from 3.3 in patients aged 18-39 years to 1.6 in those aged >or=75 years. However, the rate difference was 1.2 per 1000 person-years in the youngest age group and increased to 19.7 per 1000 person-years in those aged >or=75 years. Among patients with a prior CVD event, the rate ratios and rate differences were not increased in rheumatoid arthritis.
CONCLUSIONS: This study confirms that rheumatoid arthritis is a risk factor for CVD events and shows that the rate ratio for CVD events among subjects with rheumatoid arthritis is highest in young adults and those without known prior CVD events. However, in absolute terms, the difference in event rates is highest in older adults.

Entities:  

Mesh:

Year:  2006        PMID: 16793844      PMCID: PMC1798453          DOI: 10.1136/ard.2005.050377

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Lipid profiles in untreated patients with rheumatoid arthritis.

Authors:  Y B Park; S K Lee; W K Lee; C H Suh; C W Lee; C H Lee; C H Song; J Lee
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

2.  A strengthening programme for weak associations.

Authors:  K J Rothman; C Poole
Journal:  Int J Epidemiol       Date:  1988-12       Impact factor: 7.196

3.  Serum cholesterol and risk of rheumatoid arthritis in a cohort of 52 800 men and women.

Authors:  M Heliövaara; K Aho; P Knekt; A Reunanen; A Aromaa
Journal:  Br J Rheumatol       Date:  1996-03

4.  Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

Authors:  Elena Birman-Deych; Amy D Waterman; Yan Yan; David S Nilasena; Martha J Radford; Brian F Gage
Journal:  Med Care       Date:  2005-05       Impact factor: 2.983

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Cardiovascular risk factors in women with and without rheumatoid arthritis.

Authors:  Daniel H Solomon; Gary C Curhan; Eric B Rimm; Carolyn C Cannuscio; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2004-11

7.  Value of an Endpoints Committee versus the use of nosologists for validating cause of death.

Authors:  Howard D Sesso; J Michael Gaziano; Robert J Glynn; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2006-01-04       Impact factor: 2.226

Review 8.  Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

Authors:  Hilal Maradit-Kremers; Cynthia S Crowson; Paulo J Nicola; Karla V Ballman; Véronique L Roger; Steve J Jacobsen; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-02

9.  Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.

Authors:  Li Wei; Thomas M MacDonald; Brian R Walker
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

10.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s.

Authors:  N Goodson; J Marks; M Lunt; D Symmons
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

View more
  132 in total

1.  Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.

Authors:  Daniel H Solomon; Thorvardur Jon Love; Claire Canning; Sebastian Schneeweiss
Journal:  Ann Rheum Dis       Date:  2010-06-28       Impact factor: 19.103

2.  Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

Authors:  T C T M van der Pouw Kraan; C A Wijbrandts; L G M van Baarsen; A E Voskuyl; F Rustenburg; J M Baggen; S M Ibrahim; M Fero; B A C Dijkmans; P P Tak; C L Verweij
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

3.  The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.

Authors:  Yael Luck; Murray Baron; Sonia Bardakjian; Laeora Berkson; Maura Buchignani; Sabrina Fallavolita; Frédérique Giac; Geneviève Gyger; Solène Tatibouet; Marie Hudson
Journal:  Clin Rheumatol       Date:  2014-02-15       Impact factor: 2.980

Review 4.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

5.  Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.

Authors:  Zurab Nadareishvili; Kaleb Michaud; John M Hallenbeck; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-08-15

Review 6.  Co-morbidity index in rheumatoid arthritis: time to think.

Authors:  Yasser El Miedany
Journal:  Clin Rheumatol       Date:  2015-10-26       Impact factor: 2.980

7.  Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!

Authors:  Ulf Müller-Ladner; Ingo H Tarner; Christian Hamm; Uwe Lange
Journal:  F1000 Med Rep       Date:  2010-04-12

8.  Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population.

Authors:  Sharon Van Doornum; Caroline Brand; Vijaya Sundararajan; Andrew E Ajani; Ian P Wicks
Journal:  Arthritis Res Ther       Date:  2010-10-07       Impact factor: 5.156

9.  Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.

Authors:  Jonathan Graf; Rebecca Scherzer; Carl Grunfeld; John Imboden
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

10.  The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?

Authors:  Michael M Ward
Journal:  F1000 Med Rep       Date:  2009-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.